Efferon JSC

Works in Cardiovascular · Dermatology · GI & liver · Infectious disease · Renal & urogenital · Respiratory · Women's health

Efferon JSC is a clinical trial sponsor. It has 6 active clinical trials with 660 planned participants, across 7 therapeutic areas. Since 2021 it has completed 11 trials and stopped 3 early.

Trial track record · since 2021

6Active trials660 planned participants
11Completed0 with results posted
3Stopped early21% of finished trials

Pipeline · 6 active trials

StageTrialStatus

Questions about Efferon JSC

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-02.

Approve Suite is not affiliated with Efferon JSC.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.